Literature DB >> 3004913

Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells.

X C Jia, J Kalmijn, A J Hsueh.   

Abstract

Suppression of serum GH levels in immature rats is associated with delayed onset of puberty and decreased ovarian steroidogenic responsiveness to FSH. To investigate possible direct effects of GH on the differentiation of ovarian cells, granulosa cells from hypophysectomized estrogen-treated rats were cultured with FSH in the presence or absence of GH for 3 days. FSH stimulated granulosa cell LH receptor formation and steroid production in a dose-dependent manner. Concomitant treatment with GH increased LH receptor content by enhancing the action of low doses of FSH without substantial increases in the maximal response. This increase was due to an elevation in the receptor number rather than changes in their affinity for hCG. At 3 ng/ml FSH, concomitant treatment with ovine or bovine GH increased LH/hCG binding in a dose-dependent manner, with 300 ng/ml GH increasing the FSH action by about 3-fold. LH receptors in the GH-treated cells were functional, as indicated by the enhanced cAMP production of these cells in response to LH treatment. The cellular protein content in the FSH-treated cultures was slightly increased by GH (18%), but cell number and viability were unaffected. The change in cell protein content could not account for the increases in the amount of LH receptors. In addition to its effects on LH/hCG receptor content, GH also augmented FSH-stimulated progesterone and 20 alpha-hydroxy-4-pregnen-3-one production in a dose-dependent manner, with 100 ng/ml GH causing significant increases in FSH-induced progesterone production. In contrast, GH treatment did not significantly affect FSH-stimulated estrogen production. The augmentating effects of GH on LH receptor formation and progestin biosynthesis were associated with an enhancement of FSH-stimulated cAMP production. In addition, GH increased forskolin- and 8-bromo-cAMP-induced LH receptor formation and progestin production. Thus, GH-augmented LH receptor induction and progestin biosynthesis may be due to both increased cAMP production and enhanced action of cAMP. The present data have demonstrated that GH augments gonadotropin-stimulated differentiation of ovarian granulosa cells, suggesting an important regulatory role of GH in follicular growth and pubertal development.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004913     DOI: 10.1210/endo-118-4-1401

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

2.  Growth hormone (GH) and reproduction: a review.

Authors:  F Le Gac; O Blaise; A Fostier; P Y Le Bail; M Loir; B Mourot; C Weil
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

Review 3.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

Review 4.  Clinical utility of adjuvant growth hormone in the treatment of patients with polycystic ovaries undergoing in vitro fertilization.

Authors:  P G Artini; A A de Micheroux; F Taponeco; V Cela; G D'Ambrogio; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

5.  Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth, and sexual function : Evidence that such treatment does not affect sexual maturation or fertility.

Authors:  N M Gruaz; V d'Allèves; Y Charnay; A Skotther; S Ekvärn; L Fryklund; M L Aubert
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

Review 6.  Growth hormone deficiency in the transition period: body composition and gonad function.

Authors:  G Balercia; L Giovannini; F Paggi; M Spaziani; N Tahani; M Boscaro; A Lenzi; A Radicioni
Journal:  J Endocrinol Invest       Date:  2011-06-21       Impact factor: 4.256

7.  Interleukin-1 beta, interleukin-6, and growth hormone levels in human follicular fluid.

Authors:  C Huyser; F L Fourie; E Bosmans; P F Levay
Journal:  J Assist Reprod Genet       Date:  1994-04       Impact factor: 3.412

Review 8.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

9.  Growth hormone administration normalizes the ovarian responsiveness to follicle-stimulating-hormone in the early stages of the follicular maturation in women with Down syndrome.

Authors:  R M Cento; L Ragusa; C Proto; A Alberti; G Fiore; L Soranna; F Colabucci; A Lanzone
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

Review 10.  Growth hormone treatment in infertility: a short review.

Authors:  K O Lee
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.